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Background: Polycomb group proteins form multicomponent complexes that are important for establishing
lineage-specific patterns of gene expression. Mammalian cells encode multiple permutations of the prototypic
Polycomb repressive complex 1 (PRC1) with little evidence for functional specialization. An aim of this study is to
determine whether the multiple orthologs that are co-expressed in human fibroblasts act on different target genes
and whether their genomic location changes during cellular senescence.
Results: Deep sequencing of chromatin immunoprecipitated with antibodies against CBX6, CBX7, CBX8, RING1 and
RING2 reveals that the orthologs co-localize at multiple sites. PCR-based validation at representative loci suggests
that a further six PRC1 proteins have similar binding patterns. Importantly, sequential chromatin immunoprecipitation
with antibodies against different orthologs implies that multiple variants of PRC1 associate with the same DNA. At
many loci, the binding profiles have a distinctive architecture that is preserved in two different types of fibroblast.
Conversely, there are several hundred loci at which PRC1 binding is cell type-specific and, contrary to expectations, the
presence of PRC1 does not necessarily equate with transcriptional silencing. Interestingly, the PRC1 binding profiles are
preserved in senescent cells despite changes in gene expression.
Conclusions: The multiple permutations of PRC1 in human fibroblasts congregate at common rather than specific
sites in the genome and with overlapping but distinctive binding profiles in different fibroblasts. The data imply that
the effects of PRC1 complexes on gene expression are more subtle than simply repressing the loci at which they bind.Background
Polycomb-group (PcG) proteins were originally identi-
fied by their developmental effects in Drosophila but
their mammalian counterparts are implicated in a wide
variety of physiological processes, including pluripo-
tency, imprinting, differentiation and senescence [1-3].
Senescence is a state of permanent cell cycle arrest that
occurs in response to various forms of cellular stress and
acts as a front-line defense against potentially oncogenic
lesions [4,5]. Genetic ablation of a number of PcG genes* Correspondence: gordon.peters@cancer.org.uk
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article, unless otherwise stated.results in premature senescence, in part because of de-
repression of the CDKN2A tumor suppressor [6,7].
PcG proteins operate within multi-component com-
plexes, the best characterized of which are termed Poly-
comb repressive complexes 1 and 2 (PRC1 and PRC2)
[1-3]. PRC2 is responsible for tri-methylating histone H3
on lysine 27 (H3K27me3), generally considered to be a
mark of transcriptional repression, and apart from dupli-
cation of the Ezh subunit, the core components of the
complex are conserved between flies and mammals [8].
In contrast, the PRC1 components have undergone con-
siderable expansion during evolution. The prototypic PRC1
complex in Drosophila comprises equimolar amounts of
Polycomb (Pc), Posterior sex combs (Psc), Polyhomeotic
(Ph) and Sex combs extra (Sce) [9,10]. However, as human
cells encode five Pc, six Psc, three Ph and two Sce orthologs,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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ical analyses indicate that a typical PRC1 complex con-
tains a single representative from each gene family
[7,12-15] and, although it has not been formally shown
that all of the orthologs participate in functional PRC1-
type complexes, there could in principle be up to 180
different permutations. The situation is further compli-
cated by the ability of the Psc and Sce subunits to form
functional complexes that contain RYBP or YAF2 ra-
ther than the Pc and Ph orthologs [15-17].
The Psc and Sce subunits combine to form an E3 ubi-
quitin ligase that mono-ubiquitinates histone H2A on ly-
sine 119 (H2AK119), a modification that is also associated
with transcriptional repression [1-3]. However, it has not
been conclusively established whether the H2AK119
modification is essential for blocking transcription and
whether it is carried out by the prototypic PRC1 or alter-
native complexes [15-20].
The reason for the expansion of PRC1 families is unclear
as there is currently little evidence for functional diversifi-
cation [15,21-23]. It has been generally assumed that par-
ticular family members operate in different cell lineages or
that the various permutations of PRC1 regulate specific
sets of target genes [15,24]. For example, CBX7 is the
predominant Pc ortholog in embryonic stem (ES) cells
but its expression declines during differentiation and it
is replaced by CBX2, CBX4 and CBX8 [24,25]. If these
proteins bind selectively, as suggested, then the number
of PcG target genes would potentially increase in cell
types that express multiple variants of the canonical
PRC1 complex.
Here we investigate the genome-wide distribution of the
PRC1 components expressed in two strains of normal hu-
man fibroblasts (HFs), a somatic cell type required for the
physical integrity of multiple tissues and the classical
model for the study of cellular senescence. Contrary to ex-
pectations, we find that three Pc orthologs (CBX6, 7 and
8) and both Sce proteins (RING1 and RING2) have very
similar binding patterns throughout the genome with little
evidence for target gene specificity. Moreover, by assem-
bling a panel of antibodies that support chromatin immu-
noprecipitation (ChIP) of the endogenous proteins, we
find that 11 of the PRC1 core components expressed in
HFs display virtually identical binding patterns at repre-
sentative loci. Importantly, sequential ChIP with anti-
bodies against different members of the Pc, Ph and Sce
families implies that multiple variants of PRC1 associate
simultaneously with the same chromatin. At many loci,
the binding patterns have an inherent architecture that is
faithfully conserved between the two strains of HF but at
an equivalent number of loci the binding is strain specific.
Surprisingly, there is no strict correlation between the
presence and position of the PRC1 peaks and RNA ex-
pression from adjacent gene(s). Moreover, the genomiclocation of the Pc orthologs remains unchanged in senes-
cent HFs. The findings are consistent with the idea that
mammalian PRC1 proteins congregate as complexes of
complexes and that their control over gene expression is
more subtle than simply blocking transcription of the
genes to which they bind.
Results
Expression of PRC1 genes in human fibroblasts
Most studies of mammalian PcG proteins and their poten-
tial target genes have focused on ES cells and in vitro
models of differentiation. We chose to investigate the situ-
ation in HFs, in part because of the evidence linking PRC1
proteins with senescence, via effects on the CDKN2A
locus [26], but also because HFs express a much broader
repertoire of PRC1 genes than ES cells. For example, deep
sequencing of RNA isolated from the BF strain of adult
breast fibroblasts and the Hs68 strain of neonatal foreskin
fibroblasts suggested that 15 of the 16 genes encoding core
PRC1 components are expressed, albeit at variable levels
(Figure 1A). Among the four gene families, the highest ex-
pression was observed for CBX4, MEL18, HPH2 and
RING1. In contrast to mouse embryo fibroblasts [24,25],
the HFs expressed substantial amounts of CBX7 whereas
CBX2 was barely detectable at the RNA level.
Multiple PRC1 complexes bind simultaneously at the
CDKN2A locus
The RNA expression data implied that HFs have the po-
tential to express many different permutations of PRC1
and are therefore an ideal system in which to investigate
target specificity. Using the CDKN2A locus as a test bed
for antibody evaluation, we assembled a panel of custom-
made and commercially available reagents that support
ChIP of endogenous PRC1 components in primary HFs.
A number of PRC1 components have been previously
located at CDKN2A using a validated set of PCR primers
(Figure 1B and [7,12,27]) but our survey has added
substantially to the list of proteins involved. We found
that four Pc proteins (CBX4, 6, 7 and 8), two Psc proteins
(BMI1 and MEL18), all three Ph orthologs (HPH1, 2 and
3) and both Sce proteins (RING1 and 2) were not only
enriched at the CDKN2A locus but had virtually identical
binding profiles (Figure 1C). Importantly, we confirmed
that the antibodies did not cross-react with members of
the same family, even when they were over-expressed
(Additional file 1: Figure S1).
Genome-wide profiling of PRC1 binding sites
To determine whether PRC1 proteins are co-localized at
other target genes, we conducted genome-wide ChIP-
sequencing (ChIP-seq) with antibodies against three of
the Pc orthologs and both Sce orthologs for the BF and
Hs68 fibroblasts. We reasoned that by comparing the
INK4bARFINK4a




























































































































































Figure 1 (See legend on next page.)
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Figure 1 Multiple PRC1 components have similar binding profiles at the CDKN2A locus. (A) Relative expression levels of the core PRC1
components in the BF and Hs68 strains of primary fibroblasts. The numbers are mean FPKM values from four independent RNA-sequencing
analyses. CDK4 and TUBB are shown as controls. (B) Genomic organization of the human CDKN2A/B locus with colored boxes depicting the exons
that encode p16INK4a, p14ARF and p15INK4b. The locations of primer sets used for ChIP analyses are shown below, numbered according to Bracken
et al. [27]. The sequences are described in Additional file 6: Table S3. (C) Examples of ChIP data using antibodies against four Pc proteins (blue),
two Psc proteins (pink), three Ph orthologs (orange) and both Sce proteins (green) using the indicated primer sets. Binding is shown as the
percentage of input. Non-specific antibodies or pre-immune serum were used as controls as appropriate (shown in grey). (D) Screenshot showing
DNA sequence tag densities at the CDKN2A locus following ChIP-sequencing with the indicated antibodies in BF fibroblasts. The maximum
coverage for each track is shown on the left and a size bar is included above the IGV screenshot. ChIP, chromatin immunoprecipitation; kb,
kilobase; FPKM, fragments per kilobase of gene per million fragments mapped; IGV, Integrative Genomics Viewer.
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http://genomebiology.com/2014/15/2/R23binding profiles of CBX6, CBX7 and CBX8, we could as-
certain whether they regulate distinct or overlapping sets
of target genes in HFs. Conversely, as every catalytically
active PRC1 complex should contain either RING1 or
RING2, the combined dataset should provide an impres-
sion of all PRC1 binding sites in the genome, which would
complement the CBX profiles. For reference purposes,
we also generated ChIP-seq profiles for H3K27me3 and
H3K4me3 for the same cells. CDKN2A is shown as an ex-
ample in Figure 1D. Sequencing was performed on the
Illumina GAIIx platform and typically generated between
12 and 60 million 36-bp reads that could be mapped to
the hg19 release of the human genome. The raw and proc-
essed data have been deposited under GEO accession
number [GEO:GSE40740] [28].
Unlike the inferences drawn from other cell systems
[15,24], the five PRC1 proteins showed remarkably simi-
lar binding patterns at multiple sites throughout the
genome (Figure 2). However, the bioinformatic interpret-
ation was complicated by the fact that peak-calling algo-
rithms, such as MACS [29], often identified different
numbers of peaks at particular loci depending on the
density of the sequence reads for each antibody. To try
to clarify the situation, the ChIP-seq was repeated with
chromatin prepared from independent cell populations
rather than simply increasing the number of reads.
Merging of replicate datasets improved the definition
of coincident binding sites but did not completely re-
solve the issue of peak calling. For example, it was
common to find regions where a robust peak for all
five PRC1 proteins was flanked by weaker peaks where
only some of the proteins were scored by MACS (for
example, GATA6, UNCX and NKX2-3 in Figure 2). We
interpret these ‘foothill’ peaks as representing weaker
or less frequent contacts at the fringes of the main
body rather than evidence for specific binding by sub-
sets of PRC1 proteins.
Validation of PRC1 complex binding at representative loci
To support our interpretation of the ChIP-seq data, we
selected representative examples of target loci and per-
formed conventional ChIP followed by quantitative
PCR analyses with a series of primers that not onlycrossed each peak but allowed discrimination between
regions of high and low/no enrichment (Additional file
2: Figure S2). The PCR-based assays confirmed the re-
sults of the ChIP-seq but additionally showed that,
where tested, all of the PRC1 proteins for which we
have suitable antibodies had virtually identical binding
profiles. These findings are hard to reconcile with the
idea that different permutations of PRC1 bind selectiv-
ity at different target genes.
Multiple variants of PRC1 associate with the same DNA
As the ChIP data implied that multiple variants of PRC1
were occupying very similar positions in the genome, it
was important to know whether they were simultan-
eously associated with the same chromatin. To address
this question, we performed sequential ChIP with anti-
bodies against different members of the Pc, Ph and Sce
families. For example, chromatin precipitated with an
antibody against CBX6 was eluted from the Protein-A
beads and re-precipitated with antibodies against CBX7,
CBX8 or an irrelevant IgG control. The recovered chro-
matin was then interrogated with PCR primers that
demonstrate localized enrichment at CDKN2A, and at
other loci (Figure 3 and data not shown). Although the
analyses were not exhaustive and do not indicate the
proportion of each protein that is sequentially precipi-
tated, the data infer that the three CBX proteins can be
associated with the same DNA, and that this holds true
for the three HPH proteins and both RING proteins. As-
suming that the canonical PRC1 complex contains a sin-
gle representative from each of the component families,
and that they can freely assort, the data imply that mul-
tiple permutations of PRC1 congregate at common sites
throughout the genome.
Location of PRC1 binding sites relative to potential
target genes
Irrespective of the number of PRC1 proteins detected
at any one site, an obvious point of interest was the rela-
tion between the binding profiles and potential target
genes. We compiled a list of candidate loci at which ChIP-
seq detected at least one CBX, one RING protein and




















































































































Figure 2 (See legend on next page.)
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Figure 2 Representative examples of ChIP-sequencing data at annotated loci. The panels show DNA sequence tag densities observed
following ChIP-sequencing with the indicated antibodies at GATA6 (A), MEIS1 (B), UNCX (C), ZIC4 (D) and NKX2-3 (E), in the BF strain of HFs. Panels
(F) and (G) show the equivalent ChIP-sequencing data for the TLX2 and LBX1 loci in both BF and Hs68 cells. The maximum coverage for each
track is shown on the left and a size bar is included above the IGV screenshot. The genomic organization of each locus according to the UCSC
genome browser is shown below, with arrows indicating the direction of transcription. HF, human fibroblast; kb, kilobase; IGV, Integrative
Genomics Viewer.
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http://genomebiology.com/2014/15/2/R23start site (TSS) as the initial criterion. However, a striking
feature of the data was that many of the ChIP-seq peaks
had a complicated architecture that would be inconsistent
with a normal distribution around a single binding site. It
was also common to find multiple discrete peaks at the
same locus and there was no simple relation between the





























































Figure 3 Sequential ChIP of PRC1 orthologs at the CDKN2A locus. (A)
by CBX6 and CBX7, or CBX6 followed by CBX7 and CBX8 as indicated. An i
recovered chromatin was subjected to quantitative PCR with primers that d
(B and C) Equivalent analyses with antibodies against HPH1, HPH2 and HPpotential target genes. The bioinformatically compiled lists
were therefore edited manually to try to resolve ambigu-
ities (Additional file 3: Table S1). For example, where
peaks overlapped adjacent coding and non-coding loci,
preference was given to the annotated coding gene.
Most published descriptions of PRC1 and H3K27me3



































Sequential ChIP was performed with antibodies against CBX8 followed
rrelevant antibody was used as a control (shown in grey). The
etect specific PRC1 enrichment at CDKN2A (as described in Figure 1).
H3 (B) or RING1 and RING2 (C). ChIP, chromatin immunoprecipitation.
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http://genomebiology.com/2014/15/2/R23regions within a few kilobase pairs from the TSS. Al-
though this was a common scenario in our target gene
list (summarized in Figure 4), the distance from the TSS
was very variable (up to 620 kb) and in many cases
exceeded the +/- 10 kb range that is typically used in
this type of analysis. Importantly, at a substantial num-
ber of loci the PRC1 peaks were much closer to a tran-
scription end site (TES) than a TSS. For example, the
simple peak just downstream of the MEIS1 gene is ap-
proximately 150 kb from the nearest TSS, which is at
the 5' end of MEIS1 and marked by H3K4me3 (Figure 2B
and Additional file 2: Figure S2C). There is no other an-
notated locus for 500 kb in either direction. We esti-
mated that around 15% to 16% of the potential target
loci had peaks that were most closely associated with the
3' end of the transcription unit (Figure 4) but acknow-
ledge that for short genes, this classification is debatable.
The third group of potential targets, representing
about 18% of the total, had PRC1 peaks associated with
both ends of the transcription unit. However, within
this category, there were a number of distinct scenarios
(Figure 4). Some loci were flanked by relatively discrete
peaks that did not spread across the body of the gene





















Figure 4 Location of PRC1 complexes relative to annotated loci. (A) D
relative to a typical gene and the proportions of the peaks that fall into ea
showing the number of potential target genes in the two cell types and th
that are actively transcribed in BF and Hs68 cells. ChIP, chromatin immunopeaks at some distance from the TSS or TES, but a more
common pattern was where peaks were located up-
stream, downstream and within the transcription unit
(for example, ZIC1 and ZIC4 in Figure 2D). Where such
complicated profiles occurred at closely linked genes, it
was not possible to assign the peaks to specific loci.
In conclusion, our data suggest that there is an inher-
ent complexity in the shape of the PRC1 peaks and their
location relative to potential target genes. These intrica-
cies in the ChIP-seq profiles have been largely ignored
or masked by bioinformatics-based meta-analyses.
Comparison of the PRC1 binding profiles in different
fibroblasts
Despite some residual ambiguities, the peak classifica-
tion scheme yielded very similar conclusions regarding
the numbers of putative target genes in the two strains
of HF and the proportions in each category (Figure 4A).
A total of 986 loci were scored as candidate PRC1
targets in BF cells compared with 1,099 in Hs68 cells
(Additional file 3: Table S1). Importantly, although there
were 685 loci in common between the gene lists, 301





























iagrammatic representation of the location of ChIP-sequencing peaks
ch category in the BF and Hs68 strains of HFs. (B) Venn diagram
e overlap between the datasets. (C) Proportions of PRC1 target genes
precipitation; HF, human fibroblast.
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lar in the two HF strains. This was particularly striking at
loci where the peaks had a complicated architecture. In-
deed, many of the peaks appeared to resolve into evenly
spaced arrays, suggesting some degree of periodicity (for
example, TLX2 and LBX1 in Figure 2F, G). As the same
periodicity was observed with antibodies against all five
PRC1 proteins, with independent preparations of chroma-
tin, and in both strains of HF, it seems unlikely to be a
technical artefact and warrants further investigation.
Where the PRC1 profiles appeared to be strain specific, the
differences were generally unambiguous. For example,TBX2
is a PRC1 target in BF but not Hs68 cells, whereas the
adjacent TBX4 gene is occupied in both (Figure 5 and
Additional file 4: Figure S3). Similarly,NRN1 and RUNX3 are
targets inHs68 but not BF cells, whereasMEIS1 shows the re-
ciprocal pattern of occupancy (Additional file 2: Figure S2 and
Additional file 4: Figure S3). Among the most striking exam-
ples of strain-specific profiles are those for the fourHOXgene
clusters (Additional file 5: Figure S4). For example, whereas
the PRC1 proteins occupy the posterior but not the anterior
regions of the HOX gene clusters in BF cells, the pattern in
Hs68 cells is more complicated, with interspersed binding
and non-binding domains across the entire locus.
Relating PRC1 occupancy to gene expression
Although most of the PRC1-occupied loci were devoid of
the H3K4me3 mark, consistent with transcriptional re-
pression, a substantial proportion (38%) had an H3K4me3
peak associated with the TSS (for example, TBX2 and
TBX4 in Figure 5). To explore the relation between PRC1
occupancy and gene expression more directly, we used
strand-specific RNA-sequencing (RNA-seq) to profile the
transcriptome in BF and Hs68 cells and cross-referenced
the resulting datasets with the list of potential target genes
compiled from the ChIP-seq. The analyses were con-
ducted on two independently prepared RNA samples from
each strain of HF, and an arbitrary threshold of ten read
counts in duplicate samples was taken as evidence of ac-
tive transcription (Additional file 3: Table S1). On this
basis, 28% of the PRC1 target genes in each cell type were
deemed to be transcriptionally active, whereas 72% were
considered silent (Figure 4C). This compares with a 47%
to 53% ratio for all expressed and non-expressed genes.
At representative loci selected for validation, there was
excellent agreement between the results obtained by
quantitative reverse transcription PCR (qRT-PCR) and the
RNA-seq data. For example, NRN1 and RUNX3 were
expressed in BF but not Hs68 cells, ISL2 and GATA2 were
expressed in Hs68 but not BF, whereas MEIS1 was
expressed in both, albeit at different levels (Figure 6). An
obvious implication is that the presence of PRC1 at a locus
does not necessarily equate with repression, although for-
mal proof would require analyses at the single cell level.The genomic landscape of Polycomb binding is
maintained at senescence
One of the motivations for profiling Pc orthologs in HFs
was to understand the role of PRC1 complexes in the
regulation of CDKN2A and senescence. We therefore
conducted ChIP-seq for CBX7 and CBX8 in Hs68 cells
that had been to grown to replicative senescence, as
judged by a failure to double after 6 to 8 weeks in cul-
ture. As shown in Figure 7A, staining for senescence-
associated β-galactosidase (SA-βgal) activity indicated
that the cell populations were uniformly senescent and
the anticipated accumulation of p16INK4a and decline of
p18INK4c levels [30] were confirmed by immunoblotting
(Figure 7B). Remarkably, the CBX binding landscapes in
the senescent cells were qualitatively indistinguishable
from those in proliferating Hs68 cells, in terms of the
architecture and locations of the peaks (Figure 7C).
However, there was an overall reduction in the density
of sequence reads. This was particularly notable for
CBX7, potentially reflecting the decline in the total levels
of CBX7 in senescent cells (Figure 7B), as previously
reported [31]. Thus, although there was no evidence
for dramatically altered binding profiles, such as those
observed between the two strains of HFs, there could
be relatively subtle changes in the amounts of the dif-
ferent Pc orthologs associated with specific loci. Such
changes are presumably enough to cause upregulation
of p16INK4a.
Discussion
It has been widely assumed that the different variants of
PRC1 encoded by mammalian cells are likely to repress
different sets of target genes or to substitute for one an-
other in different contexts. Here we suggest a different
scenario based on evidence that PRC1 complexes act
collectively rather than individually and can be associ-
ated with transcriptionally active genes. It is not yet
known how many of the potential permutations of the
canonical PRC1 complex can be formed in mammalian
cells as the existing biochemical data do not provide a
strong case for preferential associations between particu-
lar subunits. Allowing for free assortment, HFs have the
potential to express multiple variants of PRC1 as judged
by detection of transcripts for 15 of the 16 core compo-
nents. We might therefore have expected to see CBX6, 7
and 8 peaks in discrete locations in the ChIP-seq data,
in line with recent suggestions [15,24], but instead found
that they are largely co-localized. Although there were
sites where subsets of the CBX proteins were detected,
the signals were generally weaker compared to the loci
at which all three CBX proteins were detectable. Like-
wise, we might have expected to see selective binding of
RING1 and RING2, particularly as they can participate


































Figure 5 Correlation of ChIP-sequencing and RNA-sequencing data at the TBX2 and TBX4 loci. (A) Profiles of DNA sequence tag densities
across the TBX2 and TBX4 loci following ChIP-sequencing with the indicated antibodies for BF and Hs68 cells. (B) Examples of duplicate RNA-
sequencing analyses across the TBX2 and TBX4 loci for BF and Hs68 cells. kb, kilobase; RNA-seq, RNA-sequencing.
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http://genomebiology.com/2014/15/2/R23others have shown [15-17], they mostly occupied the
same positions as the CBX proteins.
As our findings appeared to be odds with recent re-
ports, we re-examined the published datasets to seek
a potential explanation, focusing on studies that com-
pared the binding of different members of the same pro-
tein family. For example, an extensive survey of 29
chromatin regulators in the K562 human leukemia cellline included data showing that endogenous CBX2 and
CBX8 had remarkably coincident binding profiles [32].
Although not explicitly discussed, the inference is that
CBX2 and CBX8 have common targets. In contrast, a
separate study that compared the binding of epitope-
tagged versions of the Psc family in 293T cells concluded
that they bind selectively to different categories of target


















































































Figure 6 (See legend on next page.)
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Figure 6 Correlation of ChIP-sequencing and RNA-sequencing in BF and Hs68 cells. (A) Comparison of CBX7 binding profiles (top tracks)
and RNA-sequencing tag densities at the indicated loci in BF and Hs68 cells. For comparative purposes, the sequence tag densities are plotted on
equivalent scales. (B) Reverse transcription and quantitative PCR validation of the RNA-sequencing data at the indicated loci. Relative expression
levels in BF cells (purple) and Hs68 (tan) cells were calculated relative to RPS17 as an internal standard and plotted on a logarithmic scale. The
color-coded B and H symbols above the graph indicate whether the locus is occupied by PRC1 complexes in BF (purple) or Hs68 (tan) cells. Note
that DKK2, GAD1, FGF10, SFRP2, FOXE1 and TBX4 are PRC1 targets in both cell backgrounds. ChIP, chromatin immunoprecipitation; kb, kilobase;
RNA-seq, RNA-sequencing.
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loci were co-occupied by multiple Psc family members.
Along similar lines, it was reported that, in mouse em-
bryoid bodies, Cbx2 and Cbx4 bind at both overlapping
and non-overlapping sets of target genes [24]. The evi-
dence for specificity was based largely on differences in
the sequence read densities achieved with different anti-
bodies and there was considerable variation in the num-
bers of peaks identified with each reagent. Of note, the
data imply that 90% of the Cbx2 peaks overlap with
those of Cbx4.
Despite their different interpretations, these published
datasets are consistent with the co-localization of PRC1
complexes at multiple sites in the genome. Although we
did not detect CBX2 in HFs, we extended the evidence
for co-localization to include 11 PRC1 components that,
as judged by ChIP-PCR with multiple primer sets, had
virtually identical binding patterns at representative loci.
Importantly, our ability to perform sequential ChIP with
antibodies specific for different members of the Pc, Ph
and Sce families argues against the idea that the com-
plexes are acting redundantly in different cells. Rather, a
proportion of these complexes must be simultaneously
associated with the same DNA.
While our findings do not exclude an element of se-
lectivity in the association of specific PRC1 complexes
with specific loci, the overwhelming impression is that
they congregate at common sites. One possibility is that
they form multimeric assemblies analogous to the Pc
bodies described for Drosophila [33-35]. Mammalian Pc
bodies might comprise multiple permutations of PRC1
rather than multimers of the same complex. Although
the ChIP-seq data do not provide a three-dimensional
picture, the fact that multiple complexes are co-localized
along the genome implies that they are also co-localized
in space. To our knowledge, this possibility has not been
considered in the existing literature and most discus-
sions about mammalian Pc bodies have centered on their
visualization by fluorescence. In primary HFs, endogenous
RING1, BMI1 and CBX4 have been detected as multiple
speckles that are evenly distributed throughout the cell
nucleus, similar to the situation in Drosophila [33,36,37]
(data not shown). However, these early studies did not ad-
dress the co-localization of different orthologs or the
numbers of complexes that constitute a Pc body. Ourattempts to provide such evidence were hampered by a
lack of signal for most of the antibodies.
The situation in HFs is in stark contrast to the evi-
dence from human tumor cell lines where the PRC1
proteins are typically found in a small number of very
prominent nuclear bodies associated with pericentro-
meric heterochromatin [36,38-40]. Although multiple
PRC1 orthologs are co-localized in these large aggregates
[12,41-43], their functional significance has not been
established.
Another striking feature of the ChIP-seq data is that the
binding profiles have a complicated topography, often
with underlying periodicity, that is reproduced with differ-
ent antibodies, with different preparations of chromatin,
and in different cell backgrounds. The baroque nature of
the peaks makes it difficult to generalize about their loca-
tion relative to candidate target genes. Based simply on
proximity to the nearest TSS, the ChIP-seq data suggested
that PRC1 complexes are co-localized at approximately
1,000 loci in each strain of HFs. However, the distances
can be very variable and the patterns do not conform to
the idea that PRC1 proteins bind within a few kilobases ei-
ther side of the TSS, as suggested by meta-analyses of the
profiles in ES cells [15,16,24,44].
Focusing on the candidate target genes, we found that a
quarter of them are actively transcribed despite the pres-
ence of PRC1 in the adjacent DNA. Such observations are
not without precedent but PcG complexes are generally
viewed as obligate transcriptional repressors [3]. It is for-
mally possible that PRC1 complexes are present on only
one allele allowing transcription to occur from the other
but another possibility is that the assemblies of PRC1
complexes that we observe are involved in 3D interactions
that influence access to both positive and negative tran-
scription factors.
Although there were many parallels regarding the posi-
tioning of PRC1 complexes and their effects on gene ex-
pression in the two strains of HF, there were several
hundred loci at which the binding profiles were com-
pletely distinct. Fibroblasts are often considered as a
homogeneous cell type but different isolates have different
growth rates and sensitivity to senescence [45,46]. Import-
antly, HFs from different anatomical sites have character-
istic patterns of gene expression that reflect their position














































Figure 7 Genomic landscape of Polycomb orthologs is preserved at senescence. (A) Staining for senescence-associated β-galactosidase
activity in proliferating (Pro) and senescent (Sen) Hs68 cultures. (B) Immunoblotting for p16INK4a, p18INK4c, CBX7 and β-tubulin in proliferating and
senescent cells. The asterisk identifies a non-specific band detected with the CBX7 antibody. (C) Examples of ChIP-sequencing data obtained for
proliferating or senescent Hs68 cells with antibodies against CBX7 and CBX8. Note that the sequence tag densities are not plotted on equivalent
scales. kb, kilobase; Pro, proliferating; Sen, senescent.
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mal whereas Hs68 cells would be posterior/distal/dermal
[48]. As stromal fibroblasts are thought to influence tissue
architecture, via mesenchymal–epithelial interactions, it is
interesting to consider whether the signature patterns of
PRC1 occupancy represent an ‘epigenetic ZIP-code’.
Senescent fibroblasts also acquire characteristic pat-
terns of gene expression coupled to a plethora ofphenotypic and physical alterations [4,5]. At the chroma-
tin level, senescence is accompanied by the formation of
senescence-associated heterochromatin foci (SAHFs)
that comprise non-overlapping layers of H3K9me3 and
H3K27me3 modified chromatin [49-51]. However, a re-
cent study suggested that SAHF formation represents a
spatial repositioning of existing marks rather than
changes in the landscape of histone modifications in the
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ing profiles that we observed in proliferating HFs were
preserved at senescence and we did not see selective
gains or losses of PRC1 peaks that would be comparable
to the striking differences between HF strains. Taken to-
gether, our findings suggest that the effects of PRC1
complexes on gene expression are not simply dictated
by the presence or absence of PRC1 at the locus.
Conclusions
Our findings question the prevailing view that different
variants of PRC1 act on different sets of target genes
and suggest that they act collectively rather than indi-
vidually. Different types of fibroblast have distinctive
PRC1 binding landscapes but the landscapes are pre-
served at senescence. Collectively, our findings suggest
that PRC1 complexes have more subtle effects on gene
expression than simply blocking transcription of the
genes to which they bind.
Materials and methods
Cell cultures and immunoblotting
The procedures for propagation of primary human fibro-
blasts, staining for senescence-associated β-galactosidase
activity and immunoblotting were as described [30,46,52].
Chromatin immunoprecipitation
ChIP assays were performed as described previously
[53]. After sonication to obtain chromatin fragments of
between 200 and 1000 bp, solubilized chromatin was di-
luted to 1 μg/μl and incubated with the appropriate anti-
body at 4°C overnight. The antibodies are listed in
Additional file 6: Table S2 and either species-matched
irrelevant antibodies or pre-immune serum was used as
the control as appropriate. After reversal of the crosslinks,
the immunoprecipitated DNA was quantified by real-
time PCR with the primer sets described in Additional
file 6: Table S3. For sequential ChIP experiments, the
eluted chromatin was divided into equal fractions, diluted
tenfold in a dilution buffer (0.1% Na deoxycholate, 1%
Triton X-100, 1 mM EDTA (ethylenediaminetetraacetic
acid), 50 mM HEPES (4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid) pH 7.9, 150 mM NaCl) and subjected
to a further round of ChIP with either the same or a dif-
ferent antibody.
Chromatin immunoprecipitation sequencing and
bioinformatic analyses
To generate sufficient quantities of DNA for sequence
analyses, parallel ChIP reactions were performed using ap-
proximately 5 μg of antibodies with 500 μg chromatin.
The recovered material was pooled and concentrated to a
minimum of 0.2 μg/μl. DNA samples were end repaired,poly-A tailed and Illumina single-end adapters were li-
gated following the standard Illumina protocol with minor
adjustments. Agencourt AMPure XP beads at 0.8× ratio
were used to size-select out adapter dimers after adapter
ligation. The Phusion enzyme in the Illumina kit was re-
placed by the Kapa HiFi HotStart ready mix. Post PCR,
AMPure XP beads were used at a 1:1 ratio to maintain
size integrity and to allow use of the Invitrogen SizeSelect
E-gel system. We found that running the PCR before the
gel improved visualization of the product and isolation of
the correct band. Samples were finally purified with QIA-
quick gel extraction kit (Qiagen Ltd) and quality con-
trolled on the DNA 1000 BioAnalyzer 2100 chip before
clustering. Input DNA was used as a control for the ChIP-
seq analysis. Detailed protocols for library preparation and
genome-wide sequencing are available online [54-59].
The alignments were performed using Novoalign (version
2.07.14) [60] allowing for a single mismatch per read. Du-
plicates reads were removed using the Picard MarkDupli-
cates program (picard-tools package version 1.48) [61] and
peak calling was performed using MACS (version 1.4.0rc2)
[29]. The raw and processed data have been deposited
under GEO accession number [GEO:GSE40740].
RNA-sequencing, quantitative reverse transcription and PCR
Total RNA was extracted using the High Pure RNA ex-
traction Kit (Roche). RNA samples were quality con-
trolled (QC) using the 6000 Nano RNA Chip on a
BioAnalyzer 2100 (Agilent) and subjected to poly-A se-
lection using Sera-Mag oligo dT beads (Thermo Fisher
Scientific Inc). Libraries were prepared using the Direc-
tional mRNA-Seq Library Prep. v1.0. Pre-Release Proto-
col from Illumina with minor adjustments [62]. The
Phusion enzyme was replaced by the Kapa HiFi HotStart
ready mix which reduced the overall volume of the PCR
and the ratio for the Agencourt AMPure XP beads was
adjusted accordingly. The standard PCR cycling was also
changed to match the concentration of the total RNA
from the initial QC. After passing the final QC, the li-
braries were subjected to cluster formation and then 72-
bp single-end sequencing on a GAIIx analyzer [62].
Sequenced reads were aligned using RSEM (version
1.2.4) [63]. Each lane of the GAIIx produced approximately
9 to 20 million unique reads that mapped to RefSeq genes
archived in the Illumina iGenomes resource [64].
For qRT-PCR validation, cDNAs were generated from
0.5 to 1 μg of RNA using MultiScribe reverse transcript-
ase and random hexamer primers (Applied Biosystems).
Of the cDNA, 1/50 was used as a template for quantita-
tive PCR with POWER SybrGreen (Applied Biosystems).
RPS17 was used as an internal standard. Relative RNA
levels were presented either as normalized to RPS17, or
as fold-difference between the normalized values. Primer
sequences can be found in Additional file 6: Table S4.
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Additional file 1: Figure S1. Evaluation of antibody specificity.
(A) Flag-tagged versions of human CBX2, CBX4, CBX6, CBX7 and CBX8
were expressed in 293T cells by transient transfection of pcDNA6-based
vectors. Cell lysates were precipitated with an anti-Flag antibody,
ractionated by SDS-PAGE and immunoblotted with the indicated
antibodies. Although multiple products were detected, presumably
reflecting premature termination or post-translational cleavage, the CBX6
antibodies only detected Flag-CBX6, the CBX7 antibodies only detected
Flag-CBX7 and the CBX8 antibodies only detected Flag-CBX8. (B) Equivalent
analyses with cells expressing Flag-tagged versions of HPH1, HPH2 and
HPH3. (C) Similar evaluation of antibodies against RING1 and RING2.
(D) Lysate from cells expressing Flag-tagged CBX4 (left) or CBX6 (right)
were immunoprecipitated with antibodies against CBX4, 6, 7 and 8 as
indicated. Following SDS-PAGE, the Flag-tagged proteins were identified by
immunoblotting. Ig refers to the position of the immunoglobulin
heavy chain.
Additional file 2: Figure S2. ChIP-PCR analyses of multiple PRC1
proteins at representative loci. Each dataset includes a screenshot of the
CBX7 binding profile across the locus (top), with a diagram showing the
position of the PCR primer sets relative to the organization of the
suspected target gene. The primer sequences are described in Additional
file 6: Table S3. The panels show the enrichment observed with the
indicated antibody at each primer set as a percentage of input. Grey bars
show values for a control IgG antibody. (A) GATA6 in BF cells, (B) CCND2
in BF cells, (C) MEIS1 in BF cells and (D) NRN1 in Hs68 cells.
Additional file 3: Table S1. List of candidate PRC1 target loci in the BF
and Hs68 strains of HF. Alphabetic list of loci associated with PRC1
ChIP-seq peaks in HFs, showing the number of PRC1 proteins identified
at the locus for the BF and Hs68 strains. TRUE and FALSE indicate
whether the locus is transcriptionally active in BF and Hs68, as judged by
RNA-sequencing.
Additional file 4: Figure S3. ChIP-PCR showing differential binding of
PRC1 proteins in BF and Hs68 cells. Each dataset includes a screenshot of
the CBX7 binding profile across the locus (top), with a diagram showing
the position of the PCR primer sets relative to the organization of the
suspected target gene. The primer sequences are described in Additional
file 6: Table S3. The panels show the enrichment observed with the
indicated antibody at each primer set as a percentage of input.
Grey bars show values for a control IgG antibody. (A) TBX2, (B) TBX4
and (C) RUNX3.
Additional file 5: Figure S4. ChIP-seq and RNA-sequencing profiles of
the HOX clusters in BF and Hs68 cells. Upper tracks in each figure show
the profiles of DNA sequence tag densities following ChIP-seq with
antibodies against CBX6, CBX7, CBX8, H3K27me3 and H3K4me3 in the BF
and Hs68 strains of HDF as indicated. The lower tracks show duplicate
RNA-sequencing data for the corresponding genomic regions in either
BF or Hs68 cells. The tag densities were normalized to the same
maximum (numbers on left).
Additional file 6: Table S2. List of antibodies used for ChIP. Table S3.
List of oligonucleotide primers for PCR analysis of immunoprecipitated
chromatin. Table S4. List of oligonucleotide primers used to assess RNA
levels by reverse transcription and quantitative PCR.Abbreviations
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